Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Sidley says it is advising Telix on its $1.65 billion ITM acquisition
Sidley said it is representing Telix Pharmaceuticals in its $1.65 billion acquisition of Germany-based ITM Isotope Technologies Munich. The firm said ITM specializes in radioisotope production and radiopharmaceutical development, and the transaction will expand Telix’s manufacturing capabilities and add a complementary therapeutic pipeline.
Key points
- Sidley said the deal includes up to $700 million in additional contingent consideration.Sidley
- The firm said those payments depend on regulatory approvals and commercial sales milestones.Sidley
- Sidley identified Sharon Flanagan, Pran Jha and Ellen Hunter among the transaction’s U.S. team leaders.Sidley
- The firm said its advisers cover tax, antitrust, healthcare, financing, privacy and foreign investment issues.Sidley